Visit MarShield at ASTRO 2026 for Shielding for Your Oncology Department

Radiation shielding is a critical component of radiation oncology because it protects patients, healthcare workers, visitors, and the public from unnecessary exposure to ionizing radiation while allowing effective cancer treatment to be delivered safely.

If you’re heading to Boston for the American Society for Radiation Oncology (ASTRO) annual meeting this September, you already know the pressure to provide fully compliant protection that passes every regulatory review and keeps staff and patients safe from increasingly potent isotopes.

You need radiation shielding engineered and manufactured around imaging centers, treatment rooms, your isotopes, and your timeline, from a partner who understands why that matters.

MarShield has spent more than 45 years designing, building, and improving shielding. We’ll be at ASTRO 2026 in Booth #1641, ready to talk through the challenges above with the people who live them every day.

See what radiation shielding products which we are bringing to the show:

Why ASTRO Matters for Nuclear Medicine Protection

ASTRO puts the future of radiation oncology and radiopharmaceutical therapy in one room. Leaders and professionals from the radiation oncology community meet, share ideas, find new perspectives, and also explore opportunities across the industry. It is where the shielding decisions behind every new isotope, renovated hot lab, and expanded therapy suite get made. A direct conversation at the event with someone who’s engineered this exact problem before can save your department months of second-guessing a decision you’ll live with for years.